Optimization of retroviral vector generation for clinical application
- 6 July 2001
- journal article
- Published by Wiley in The Journal of Gene Medicine
- Vol. 3 (5) , 427-436
- https://doi.org/10.1002/jgm.204
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Generation of Retroviral Packaging and Producer Cell Lines for Large-Scale Vector Production and Clinical Application: Improved Safety and High TiterMolecular Therapy, 2000
- Gene therapy turns the cornerNature Medicine, 2000
- Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 DiseaseScience, 2000
- Human Gene Marker/Therapy Clinical Protocols (Complete Updated Listings)Human Gene Therapy, 1999
- High Efficiency Gene Transfer to Human Hematopoietic SCID-Repopulating Cells Under Serum-Free ConditionsBlood, 1998
- Gene therapy - promises, problems and prospectsNature, 1997
- Human somatic gene therapy: progress and problemsJournal of Internal Medicine, 1995
- Improved Methods of Retroviral Vector Transduction and Production for Gene TherapyHuman Gene Therapy, 1994
- Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells.Proceedings of the National Academy of Sciences, 1993
- Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection.Molecular and Cellular Biology, 1990